Literature DB >> 31730271

Variants in nuclear factor I genes influence growth and development.

Martin Zenker1, Jens Bunt2, Ina Schanze1, Denny Schanze1, Michael Piper2,3, Manuela Priolo4, Erica H Gerkes5, Richard M Gronostajski6, Linda J Richards2,3, Julie Vogt7, Marja W Wessels8, Raoul C Hennekam9.   

Abstract

The nuclear factor one (NFI) site-specific DNA-binding proteins represent a family of transcription factors that are important for the development of multiple organ systems, including the brain. During brain development in mice, the expression patterns of Nfia, Nfib, and Nfix overlap, and knockout mice for each of these exhibit overlapping brain defects, including megalencephaly, dysgenesis of the corpus callosum, and enlarged ventricles, which implies a common but not redundant function in brain development. In line with these models, human phenotypes caused by haploinsufficiency of NFIA, NFIB, and NFIX display significant overlap, sharing neurodevelopmental deficits, macrocephaly, brain anomalies, and variable somatic overgrowth. Other anomalies may be present depending on the NFI gene involved. The possibility of variants in NFI genes should therefore be considered in individuals with intellectual disability and brain overgrowth, with individual NFI-related conditions being differentiated from one another by additional signs and symptoms. The exception is provided by specific NFIX variants that act in a dominant negative manner, as these cause a recognizable entity with more severe cognitive impairment and marked bone dysplasia, Marshall-Smith syndrome. NFIX duplications are associated with a phenotype opposite to that of haploinsufficiency, characterized by short stature, small head circumference, and delayed bone age. The spectrum of NFI-related disorders will likely be further expanded, as larger cohorts are assessed.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  NFIA; NFIB; NFIX; intellectual disability; macrocephaly; nuclear factor one

Mesh:

Substances:

Year:  2019        PMID: 31730271     DOI: 10.1002/ajmg.c.31747

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  5 in total

1.  Recurrent NFIA K125E substitution represents a loss-of-function allele: Sensitive in vitro and in vivo assays for nontruncating alleles.

Authors:  Tomoko Uehara; Rikako Sanuki; Yurie Ogura; Atsushi Yokoyama; Takeshi Yoshida; Hiroshi Futagawa; Hiroshi Yoshihashi; Mamiko Yamada; Hisato Suzuki; Toshiki Takenouchi; Kohei Matsubara; Hiromi Hirata; Kenjiro Kosaki; Toshiyuki Takano-Shimizu
Journal:  Am J Med Genet A       Date:  2021-05-11       Impact factor: 2.802

2.  Deletion of NFIX results in defective progression through meiosis within the mouse testis†.

Authors:  Raul Ayala Davila; Cassy Spiller; Danyon Harkins; Tracey Harvey; Philip W Jordan; Richard M Gronostajski; Michael Piper; Josephine Bowles
Journal:  Biol Reprod       Date:  2022-06-13       Impact factor: 4.161

3.  An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.

Authors:  Zhifen Zhou; Yujing Li; Huimin Xu; Xiaowei Xie; Zibin He; Song Lin; Ruofei Li; Shouheng Jin; Jun Cui; Hai Hu; Feng Liu; Su Wu; Wenbin Ma; Zhou Songyang
Journal:  iScience       Date:  2022-01-25

4.  A de novo Non-sense Nuclear Factor I B Mutation (p.Tyr290*) Is Responsible for Brain Malformation and Lung Lobulation Defects.

Authors:  Hao Huang; Jieyuan Jin; Liping Wu; Huifen Wu; Huichun Pi; Yi Dong; Rong Xiang
Journal:  Front Pediatr       Date:  2022-03-30       Impact factor: 3.418

5.  Single-nucleus transcriptomic landscape of primate hippocampal aging.

Authors:  Hui Zhang; Jiaming Li; Jie Ren; Shuhui Sun; Shuai Ma; Weiqi Zhang; Yang Yu; Yusheng Cai; Kaowen Yan; Wei Li; Baoyang Hu; Piu Chan; Guo-Guang Zhao; Juan Carlos Izpisua Belmonte; Qi Zhou; Jing Qu; Si Wang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2021-05-30       Impact factor: 14.870

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.